Method for identifying compounds useful for increasing the functional activity and cell surface expression of CFassociated mutant Cystic Fibrosis transmembrane conductance regulator

Details for Australian Patent Application No. 2009290848 (hide)

Owner Galapagos NV

Inventors Fischer, David Frederik; Janssen, Richard Antonius Jozef; Roseboom, Marjet; Scaffidi, Amelia Katie; Tessari, Michela

Agent Davies Collison Cave

Pub. Number AU-A-2009290848

PCT Pub. Number WO2010/029118

Priority 61/191,809 11.09.08 US

Filing date 10 September 2009

Wipo publication date 18 March 2010

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

17 March 2011 PCT application entered the National Phase

  PCT publication WO2010/029118 Priority application(s): WO2010/029118

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009290849-Novel imidazolidine compounds as androgen receptor modulators

2009290847-Dynamic copolymers for workability retention of cementitious composition